Health Canada approves Jazz’s cannabis derived seizure therapy
Pharmaceutical Technology
NOVEMBER 24, 2023
Epidiolex has been approved as an adjunct therapy for seizures associated with three rare forms of epilepsy in patients aged two and older.
Fri.Nov 24, 2023
328 
Successful clinical trial for re-engineered Covid vaccine
Drug Discovery World
NOVEMBER 24, 2023
The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved Covid vaccine considered among the best in its class. The pivotal proof-of-concept testing clears the way to progress the Clamp2 technology in a range of research programmes. Project leader, Associate Professor Keith Chappell, said the preliminary clinical trial results were an ‘exciting reward’ for the team’s continued dedication and the community’s wi
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bayer expands German manufacturing facilities to fulfill supply demand
Pharmaceutical Technology
NOVEMBER 24, 2023
Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.
Calliditas Therapeutics' partner Everest Medicines' announces kidney drug approval
Outsourcing Pharma
NOVEMBER 24, 2023
Calliditas Therapeutics AB announced today (November 24) that its partner Everest Medicines has revealed that China's National Medical Products Administration (NMPA) has approved Nefecon.
Vertex obtains EC approval for combination therapy to treat CF
Pharmaceutical Technology
NOVEMBER 24, 2023
Vertex Pharmaceuticals has obtained approval from EC) for the label expansion of Kaftrio plus ivacaftor to treat children with CF.
NHS urges individuals to take up cervical screening invitations
Pharma Times
NOVEMBER 24, 2023
Around 3,200 new cases of cervical cancer are diagnosed in the UK every year - News - PharmaTimes
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA
Outsourcing Pharma
NOVEMBER 24, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).
Johnson & Johnson sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Johnson & Johnson here.
Study suggests cognitive decline could be linked to hippocampus shrinkage
Pharma Times
NOVEMBER 24, 2023
The findings could benefit patients living with neurodegenerative conditions - News - PharmaTimes
F. Hoffmann-La Roche sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for F. Hoffmann-La Roche here.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Postum: A Time-Honored Coffee Alternative
XTalks
NOVEMBER 24, 2023
In the world of hot beverages, Postum occupies a unique place. Originating as a coffee alternative, this drink has carved out a niche among those seeking a caffeine-free option. To understand its enduring appeal, let’s delve into its history, ingredients and its status in today’s beverage market. The Birth of Postum Postum was born out of necessity.
Bristol-Myers Squibb sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Bristol-Myers Squibb here.
International Health Partners' Christmas campaign: Working with pharma for patients worldwide
pharmaphorum
NOVEMBER 24, 2023
International Health Partners' Christmas campaign: Working with pharma for patients worldwide Nicole.
What’s in a name: Agencies struggle to keep up with expanding drug space
Pharmaceutical Technology
NOVEMBER 24, 2023
With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
How to optimise commercial-scale ATMP manufacturing through automation
pharmaphorum
NOVEMBER 24, 2023
How to optimise commercial-scale ATMP manufacturing through automation Mike.
Novo Nordisk expands site to manufacture GLP-1 drugs
Pharmaceutical Technology
NOVEMBER 24, 2023
The expansion comes as Novo is trying to maintain strong growth in T2D after the launch of Eli Lilly’s Zepbound this month.
New patent for Abbvie drug RINVOQ
Drug Patent Watch
NOVEMBER 24, 2023
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-six patents protecting… The post New patent for Abbvie drug RINVOQ appeared first on DrugPatentWatch - Make Better Decisions.
Novartis sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Novartis here.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR)
Drug Patent Watch
NOVEMBER 24, 2023
Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are… The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.
China’s NMPA approves ArkBio’s RSV neutralising antibody drug
Pharmaceutical Technology
NOVEMBER 24, 2023
China’s NMPA has approved ArkBio IND application for its respiratory syncytial virus (RSV) neutralising antibody, AK0610.
The value of mission-orientated research in biopharma R&D
Drug Discovery World
NOVEMBER 24, 2023
Patrick Speedie , Co-Founder & Co-CEO of IN-PART , explores why a global approach is needed for the best science to prosper and the lessons industry can take from the Covid-19 pandemic. The Covid-19 pandemic unequivocally demonstrated the power of industry-academia collaboration, with the fastest ever development, testing and approval of a life-saving vaccine.
Ellipses receives orphan drug designation for selective RET inhibitor
Pharmaceutical Technology
NOVEMBER 24, 2023
Ellipses Pharma has secured ODD from the US FDA for its next generation EP0031/A400, to potentially treat solid tumours.
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA
Outsourcing Pharma
NOVEMBER 24, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).
Amgen sees highest patent filings and grants during July in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Amgen here.
Combination therapy recommended for NHS use for advanced biliary tract cancer
Drug Discovery World
NOVEMBER 24, 2023
AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) has recommended Imfinzi (durvalumab) in combination with gemcitabine and cisplatin (chemotherapy) for NHS use in England and Wales for the first-line treatment of adults with locally advanced, unresectable, or metastatic biliary tract cancer (BTC). 1 There remains a significant unmet need for new treatment options in BTC, a group of rare and aggressive cancers that occur in the bile ducts and gallbladder,
Lupin introduces triple combination Vilfuro-G in India for COPD
Pharmaceutical Technology
NOVEMBER 24, 2023
Lupin has introduced the fixed-dose triple combination drug (FDC), Vilfuro-G, to manage chronic COPD in India.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
NHS Confederation, ABPI say break down barriers to partnerships and change the lives of millions
pharmaphorum
NOVEMBER 24, 2023
NHS Confederation, ABPI say break down barriers to partnerships and change the lives of millions Nicole.
Which pharmaceutical drugs have the most drug patents in Croatia?
Drug Patent Watch
NOVEMBER 24, 2023
This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Intellectual property: Striking the balance
pharmaphorum
NOVEMBER 24, 2023
Intellectual property: Striking the balance Mike.
Let's personalize your content